arrow_back View All Dates
-
11:00am • A Regulator's View on the Future Vision for Pharmacovigilance
-
11:00am • Why do Good Clinical Practice Inspectors Do Things Differently and How can Approaches be Both Harmonized and Optimized
-
11:00am • Advancing Innovation through Essential Drug Delivery Design Outputs
-
11:00am • From Approval to Access: Integrating Patient Insights into Coverage Decisions
-
11:00am • Unintended Consequences: Effects of Inflation Reduction Act on the Future of Pharmaceutical Innovation
-
11:00am • Is Real-World Evidence Always a Last Resort?
-
11:00am • Project Orbis: Six Years Later
-
11:00am • The Role of Identification of Medicinal Products in the Future of Global Healthcare
-
11:00am • Moving Toward Pragmatism in Clinical Trials
-
11:00am • Advancing Clinical Outcomes through Digital Health Technology Innovation
-
2:15pm • Innovation at the Intersection: Clinical Operations, Data Management, and Quality Assurance on Quality-by-Design and Risk-Based Quality Management
-
2:15pm • Ushering in a New Era of Africa Healthcare
-
2:15pm • Models of Collaborations to Advance Regulatory Science: Lessons Learned
-
2:15pm • FDA Legislation 2025: How is Congress Preparing to Advance Innovation, Medical Product Safety, and FDA Funding?
-
2:15pm • Expanding Basket Trials to Cell and Gene Therapies for Rare Diseases
-
2:15pm • Clinical Care vs Research: Walking the Ethical Tightrope Between Advocacy and Coercion
-
2:15pm • Health Canada Town Hall
-
2:15pm • A Masterclass: Patient Recruitment Campaign Management
-
2:15pm • International Regulatory Harmonization for Development of Medicines: A Look at How far We’ve Come and Where We Go From Here
-
2:15pm • Divergent Regulations and a Call for Regulatory Harmonization
-
2:15pm • Leveraging the Capabilities of Artificial Intelligence and Digital Pathology in Precision Medicine
-
2:15pm • Tech-Enabled Clinical Development: Public Sector Innovation Leading the Charge
-
2:15pm • Setting the Bar High: Facilitating Quality and Acceptability of Decision-Grade Real-world Evidence
-
2:15pm • Harnessing the Power of Generative AI: From Prompt Engineering to Actionable Insights
-
2:15pm • Building a Regulatory Landscape to Support CMC Innovation
-
3:45pm • AI in Patient Care: Aspirations and Considerations
-
3:45pm • Applying Principles of Global Regulatory Collaboration to Address Chronic Disease
-
3:45pm • Enhancing Evidence Generation Across Pharmaceutical Life Cycle: The Importance of Integrating the Patient Lived Experience
-
3:45pm • Mastering the Power of Words: Elevate Performance and Compliance through Confident Communication
-
3:45pm • Spinning Plates and Juggling Chainsaws: Mastering the Art of Complex Project Management
-
3:45pm • Ethics in the Era of Precision Medicine and Advancing Technologies
-
3:45pm • Efficient Data Exchange: Drivers for End-to-End Standards Adoption
-
3:45pm • Integrating Clinical Trials and Clinical Care: The Who, What, When, Where, Why and How
-
3:45pm • Generative Intelligence in Regulatory Affairs: A Journey of Industry Implementation
-
3:45pm • Advances in Clinical Trial Linkage to Real-World Data: Bridging the Gap in Hybrid Clinical Trials
-
3:45pm • Prior Knowledge - How Experience of the Past Can Drive the Future: Patient-Centric Specs ICH Q6, Predictive Stability, Modeling ICH Q1/5C
-
3:45pm • Unlocking the Future of Clinical Trials: How the ICH M11 Digital Protocol Template Enables Key Stakeholders
-
3:45pm • Pharmacovigilance: Beyond Signal Detection and Spontaneous Reporting
-
3:45pm • WHO Town Hall: Driving Innovation and Access - Global Collaboration in Medical Product Regulation
-
3:45pm • How Soon is Too Soon? Enhancing Early Regulatory Engagement and Harmonization to Streamline Patient-Focused Drug Development
-
3:45pm • FDA Accelerated Approval Program: Putting Withdrawals in Context
